My interpretation: someone sold out of consuming frustration.
Probably into the bid so he can finally be free and clear of all the agro. Can't criticise that strategy it may yet prove to be the wisest move that seller could make.
If this is an intended shakeout it's a well concealed one. The company is not acting on behalf of my best interests. It has purposely distanced itself from logical well meaning shareholders and renegged on countless promises.
As much as I detest seeing it I cannot fault the shareholder for bailing at this price. Corporate governance is non-existent while management has become increasingly evasive. I have warned against this selloff for two years to all who would listen it should come as no surprise.
Sad? YES of course. Surprise? ....hardly looks like time for my stoploss is fast approaching. Good Luck everyone.
>>Lets all just hope that the CEO knew what he was talking about when he called for .02 by the end of the year.>>
One of the last opportunities this year is perhaps here:
The official IDenta IDenta GHB Drug Detector product introduction will be at the California Narcotics Officers Association meeting to be held in November, in Reno, Nevada. At that time executives of IDenta (Mr. Yaacov Shoham -- CEO and Mr. Baruch Glattstein -- the chief scientist) and JANT Pharmacal, the company's U.S. marketing partner, will hold a formal news conference and provide further details of their plans for the entire line of IDenta-Accutest drug detectors.
The new kits will be presented at a news conference during the November business trip (by the CEO and the Chief Scientist) in the USA and Canada, at the meetings with officials and at the CNOA conference. (RENO - NEVADA, November 16-18, 2007)
News 
Market Data 
Discover 
AI
